Page 75 - 《中国药房》2024年4期
P. 75

圣草酚咀嚼片的制备及质量评价
                                                            Δ


                                                    1, 2 #
                                            3
          秦春梦    1, 2* ,李文军 ,李辽平 ,刘 杰 ,刘松青 (1.重庆医科大学药学院,重庆 400010;2.重庆医科大学附
                            2
                                    3
          属第三医院药剂科,重庆 401120;3.重庆市力扬医药开发有限公司,重庆 400050)
          中图分类号  R944.4;R917      文献标志码  A      文章编号  1001-0408(2024)04-0449-04
          DOI  10.6039/j.issn.1001-0408.2024.04.12


          摘  要  目的  制备圣草酚咀嚼片,并对其进行质量评价。方法  选择微晶纤维素(MCC)和甘露醇为填充剂,聚乙烯吡咯烷酮
         (PVP)为黏合剂,柠檬酸和三氯蔗糖为矫味剂,硬脂酸镁为润滑剂,以湿法制粒法制备咀嚼片;以各辅料的用量为因素,以外观、口
          感、风味、质地为指标对圣草酚咀嚼片进行综合评分,利用正交实验方法优选圣草酚咀嚼片的辅料配比,并对采用优选处方制得的
          圣草酚咀嚼片的外观性状、重量差异、硬度、脆碎度、圣草酚含量、溶出度、含量均匀度进行评价。结果  最佳处方为圣草酚26.4%
         (每片含50 mg)、甘露醇45%、MCC 25%、柠檬酸0.3%、三氯蔗糖0.3%、硬脂酸镁1%、PVP 2%(以纯化水配制成5%的溶液)。处方
          验证实验中 3 批圣草酚咀嚼片的综合评分分别为 8.76、8.75、8.80(RSD=0.30%,n=3)。制得的圣草酚咀嚼片外观完整,表面光
          洁;平均片重为192.57 mg,平均硬度为57.36 N,脆碎度为0.09%,平均每片圣草酚含量为50.74 mg,30 min累积溶出度超过80%,
          含量均匀度为5.51。结论  本研究优化处方所制圣草酚咀嚼片符合2020年版《中国药典》的相关要求。
          关键词  圣草酚;咀嚼片;处方优化;正交实验;质量评价

          Preparation and quality evaluation of Eriodictyol chewable tablet
                                                          3
                        1, 2
                                                                        1, 2
                                                 3
                                    2
          QIN Chunmeng ,LI Wenjun ,LI Liaoping ,LIU Jie ,LIU Songqing (1.  College  of  Pharmacy,  Chongqing
          Medical  University,  Chongqing  400010,  China;2.  Dept.  of  Pharmacy,  the  Third  Affiliated  Hospital  of
          Chongqing  Medical  University,  Chongqing  401120,  China;3.  Chongqing  Liyang  Medical  Pharmaceutical
          Development Co., Ltd., Chongqing 400050, China)
          ABSTRACT   OBJECTIVE  To  prepare  the  Eriodictyol  chewable  tablet  and  to  evaluate  its  quality.  METHODS  The  chewable
          tablet  was  prepared  by  the  wetting  granulation  method  by  using  microcrystalline  cellulose (MCC)  and  mannitol  as  fillers,
          polyvinylpyrrolidone (PVP) as adhesive, citric acid and sucralose as flavor correction agents, magnesium stearate as lubricant. The
          comprehensive  evaluation  was  conducted  on  Eriodictyol  chewable  tablets  with  the  dosage  of  each  excipient  as  a  factor  using  the
          appearance,  taste,  flavor  and  texture  as  indicators.  The  ratio  of  excipients  was  optimized  by  orthogonal  test,  and  the  quality  of
          Eriodictyol chewable tablets prepared by optimized formulation was evaluated in terms of appearance, weight difference, hardness,
          fragility,  eriodictyol  content,  dissolution  and  content  uniformity.  RESULTS  The  optimal  formulation  was  as  follows:  26.4%
          eriodictyol (50  mg  each  piece),  45%  mannitol,  25%  MCC,  0.3%  citric  acid,  0.3%  sucralose,  1%  magnesium  stearate,  2%  PVP
         (preparing  5%  solution  using  purified  water).  The  scores  of  3  batches  of  Eriodictyol  chewable  tablets  in  the  validation  test  were
          8.76, 8.75 and 8.80 (RSD=0.30%, n=3), respectively. The Eriodictyol chewable tablet had a complete appearance and a smooth
          surface; the average tablet weight was 192.57 mg, the average hardness was 57.36 N, the fragility was 0.09%, the average content
          of  eriodictyol  per  tablet  was  50.74  mg,  the  cumulative  dissolution  within  30  min  was  exceeding  80%,  and  the  content  uniformity
          was  5.51.  CONCLUSIONS  Eriodictyol chewable  tablet prepared  by  optimal formulation  conforms  to  the  requirements of  the  2020
          edition of Chinese Pharmacopoeia.
          KEYWORDS    eriodictyol; chewable tablet; formulation optimization; orthogonal test; quality evaluation


              圣草酚[(S)-2-(3,4-二羟基苯基)-2,3-二氢-5,7-二             的方式直接被小肠细胞吸收进入体内 。相关研究表
                                                                                               [1]
          羟基-4-香豆素],又名北美圣草素,味微苦,是一种淡黄                        明,圣草酚具有抗氧化、抗炎、抗肿瘤、保肝和改善认知
          色结晶性粉末,易溶于甲醇,微溶于水;其广泛分布在植                          功能障碍等多种药理活性,但目前国内外均无圣草酚产
          物药材、柑橘类果实和多种蔬菜中,口服后以被动转运                           品上市   [2―4] 。
                                                                 咀嚼片大小、外观和普通片剂无差异,但其具有促
             Δ 基金项目 重庆市技术创新与应用发展专项面上项目(No.
                                                             进药物吸收、患者服用方便等优点,尤其适用于儿童、高
          cstc2020jscx-msxmX0123)                            龄、吞咽困难以及胃肠功能较差的患者,还可降低药物
             *第一作者 硕士研究生。研究方向:药物制剂与天然产物药理作
                                                                                [5]
                                                             对患者胃肠道的影响 。本实验以圣草酚为主药,以甘
          用机制。电话:023-60353049。E-mail:qinchunm@126.com
             # 通信作者 主任药师,博士生导师。研究方向:天然活性产物、医                 露醇、微晶纤维素(microcrystalline cellulose,MCC)、聚
          院药学。电话:023-68766377。E-mail:liusq@hospital.cqmu.edu.cn  乙烯吡咯烷酮(polyvinylpyrrolidone,PVP)等为辅料制


          中国药房  2024年第35卷第4期                                                 China Pharmacy  2024 Vol. 35  No. 4    · 449 ·
   70   71   72   73   74   75   76   77   78   79   80